Thanks to the new partnership, Eversense users will be able to view historical glucose trends in Glooko’s mobile and web apps as well as real-time data from the Eversense mobile app, according to Senseonics.
The company also noted that healthcare professionals will be able to view patients’ data in Glooko’s Population Tracker.
“Glooko has a large database of millions of users who are now able to see a clearer picture of their glucose profiles by integrating Eversense CGM data,” Senseonics president & CEO Tim Goodnow said in prepared remarks. “With personalized medicine at the forefront of health care, data integration between Eversense CGM and Glooko helps provide customized data for users, as well as healthcare providers. We believe this information can empower our community to help manage their diabetes with new insights and actions and, ultimately, improve lives.”
“We are excited to launch support for the breakthrough Eversense CGM on the Glooko platform,” Russ Johannesson, CEO of Glooko, added. “Eversense is an innovative solution for making glucose data more accessible, and we feel users will get tremendous value out of seeing this data correlated with food, activity, and medication information they log in Glooko to help them make treatment decisions.”
Johannesson also announced today that Glooko has removed the subscription fee for its mobile app for people who are not sponsored through their doctor, health plan or employer.
“Glooko strives to improve the lives of people with diabetes by providing actionable insights to inform care decisions,” he said in a statement. “I am thrilled we are removing the subscription fee for users of the mobile app – this will allow anyone who wants to use Glooko for self-management to be able to do so.”
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.